These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16289240)

  • 21. Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
    Silva AC; Almeida S; Laço M; Duarte AI; Domingues J; Oliveira CR; Januário C; Rego AC
    Mitochondrion; 2013 Nov; 13(6):801-9. PubMed ID: 23707479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology of Huntington's disease: an update].
    Roze E; Betuing S; Deyts C; Vidailhet M; Caboche J
    Rev Neurol (Paris); 2008 Dec; 164(12):977-94. PubMed ID: 18808762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations of homozygote allele carriers in Huntington disease.
    Cubo E; Martinez-Horta SI; Santalo FS; Descalls AM; Calvo S; Gil-Polo C; Muñoz I; Llano K; Mariscal N; Diaz D; Gutierrez A; Aguado L; Ramos-Arroyo MA;
    Neurology; 2019 Apr; 92(18):e2101-e2108. PubMed ID: 30867264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease.
    Rodinova M; Krizova J; Stufkova H; Bohuslavova B; Askeland G; Dosoudilova Z; Juhas S; Juhasova J; Ellederova Z; Zeman J; Eide L; Motlik J; Hansikova H
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31278192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages.
    Varani K; Bachoud-Lévi AC; Mariotti C; Tarditi A; Abbracchio MP; Gasperi V; Borea PA; Dolbeau G; Gellera C; Solari A; Rosser A; Naji J; Handley O; Maccarrone M; Peschanski M; DiDonato S; Cattaneo E
    Neurobiol Dis; 2007 Jul; 27(1):36-43. PubMed ID: 17512749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional and cellular gene expression changes in human Huntington's disease brain.
    Hodges A; Strand AD; Aragaki AK; Kuhn A; Sengstag T; Hughes G; Elliston LA; Hartog C; Goldstein DR; Thu D; Hollingsworth ZR; Collin F; Synek B; Holmans PA; Young AB; Wexler NS; Delorenzi M; Kooperberg C; Augood SJ; Faull RL; Olson JM; Jones L; Luthi-Carter R
    Hum Mol Genet; 2006 Mar; 15(6):965-77. PubMed ID: 16467349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.
    Veitch NJ; Ennis M; McAbney JP; ; Shelbourne PF; Monckton DG
    DNA Repair (Amst); 2007 Jun; 6(6):789-96. PubMed ID: 17293170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic and oxidative stress analysis in human brain samples of Huntington disease.
    Sorolla MA; Reverter-Branchat G; Tamarit J; Ferrer I; Ros J; Cabiscol E
    Free Radic Biol Med; 2008 Sep; 45(5):667-78. PubMed ID: 18588971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yugoslav HD phenocopies analyzed on the presence of mutations in PrP, ferritin, and Jp-3 genes.
    Keckarević M; Savić D; Svetel M; Kostić V; Vukosavić S; Romac S
    Int J Neurosci; 2005 Feb; 115(2):299-301. PubMed ID: 15764008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nortriptyline delays disease onset in models of chronic neurodegeneration.
    Wang H; Guan Y; Wang X; Smith K; Cormier K; Zhu S; Stavrovskaya IG; Huo C; Ferrante RJ; Kristal BS; Friedlander RM
    Eur J Neurosci; 2007 Aug; 26(3):633-41. PubMed ID: 17686041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal electrical properties of hippocampal neurons modelling early Huntington disease pathogenesis.
    Shelbourne P; Coote E; Dadak S; Cobb SR
    Brain Res; 2007 Mar; 1139():226-34. PubMed ID: 17291464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal morphology of peripheral cell tissues from patients with Huntington disease.
    Squitieri F; Falleni A; Cannella M; Orobello S; Fulceri F; Lenzi P; Fornai F
    J Neural Transm (Vienna); 2010 Jan; 117(1):77-83. PubMed ID: 19834779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Huntington's disease.
    Gusella JF; McNeil S; Persichetti F; Srinidhi J; Novelletto A; Bird E; Faber P; Vonsattel JP; Myers RH; MacDonald ME
    Cold Spring Harb Symp Quant Biol; 1996; 61():615-26. PubMed ID: 9246488
    [No Abstract]   [Full Text] [Related]  

  • 36. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.
    Squitieri F; Gellera C; Cannella M; Mariotti C; Cislaghi G; Rubinsztein DC; Almqvist EW; Turner D; Bachoud-Lévi AC; Simpson SA; Delatycki M; Maglione V; Hayden MR; Donato SD
    Brain; 2003 Apr; 126(Pt 4):946-55. PubMed ID: 12615650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal apocrine secretory cell mitochondria in a Huntington disease patient.
    Sidiropoulos C; LeWitt P; Hashimoto K
    J Neurol Sci; 2012 Dec; 323(1-2):261-3. PubMed ID: 22985800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington's disease.
    Vanisova M; Stufkova H; Kohoutova M; Rakosnikova T; Krizova J; Klempir J; Rysankova I; Roth J; Zeman J; Hansikova H
    Ultrastruct Pathol; 2022 Sep; 46(5):462-475. PubMed ID: 35946926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of energy metabolism and excitotoxic cell death in Huntington disease.
    Young AB
    Rev Neurol (Paris); 1997 Sep; 153(8-9):496-8. PubMed ID: 9683998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial Metabolism in a Large-Animal Model of Huntington Disease: The Hunt for Biomarkers in the Spermatozoa of Presymptomatic Minipigs.
    Krizova J; Stufkova H; Rodinova M; Macakova M; Bohuslavova B; Vidinska D; Klima J; Ellederova Z; Pavlok A; Howland DS; Zeman J; Motlik J; Hansikova H
    Neurodegener Dis; 2017; 17(4-5):213-226. PubMed ID: 28633139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.